Shore Capital Partners LLC-backed IZI Medical Products LLC has acquired RadioMed, the manufacturer of VISICOIL™ implantable fiducial markers, from IBA S.A.
“This represents IZI’s fourth add-on acquisition in the last 24 months and adds to our world-class portfolio of minimally invasive diagnostic and therapeutic products for the interventional radiology market,” IZI Medical CEO Greg Groenke said in a statement. “We believe that the VISICOIL™ fiducial marker is the industry leading solution due to its maximum soft-tissue fixation and minimal imaging artifact. We are excited to increase the market penetration of these products through RadioMed’s existing distribution channels and IZI’s direct sales force. These products are complementary to IZI’s existing Imaging Marker and Interventional Oncology portfolios.”
Shore Capital Partner Don Pierce, who also serves as chairman of the board at IZI, added: “IZI continues to pursue a highly targeted acquisition strategy as it focuses on building a tailored suite of products for the Interventional Radiologist. We are excited about the direction IZI is headed and will continue to invest in resources to grow the platform.”